CINCINNATI, July 6 /PRNewswire-FirstCall/ -- Kendle will conduct a telephone conference call and simultaneous Webcast on July 27 at 8:30 a.m. Eastern Time to discuss its financial results for Second Quarter 2006. A question and answer session will follow.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO)
Webcast Instructions
To access the live Webcast, go to http://www.kendle.com or http://www.videonewswire.com/event.asp?id=34557. Instructions for accessing the Webcast are provided at both sites. The Webcast will be archived at http://www.kendle.com (click on "Investors") shortly after the call for on- demand replay through 5 p.m. Eastern Time on August 25. Please note that Webcast participants will not be able to ask questions.
System requirements for the Webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.
To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on August 25 by dialing (706) 645-9291 and entering conference ID number 4134178.
About Kendle
Kendle International Inc. is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share. Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials or provided regulatory, pharmacovigilance and validation services in 70 countries.
In May 2006, Kendle announced the signing of a definitive agreement to acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. , creating the world's fourth largest provider of Phase II-IV clinical development services. The transaction is expected to close in the third quarter of 2006.
Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.CONTACT: Patty Frank, Investors, +1-513-763-1992, or Lori Dorer, Media,+1-513-345-1685, both of Kendle International Inc.
